Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-21-014754

← back to feed
Filed
Jun 21, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 21, 2021 70.22M sh
Shares Diluted Q2 2021 · Apr 30, 2021 70.46M sh
Shares Diluted Q2 2021 · Apr 30, 2021 70.46M sh
Shares Diluted Q2 2021 · Apr 30, 2020 70.1M sh
Shares Diluted Q2 2021 · Apr 30, 2020 69.99M sh
Capex Q2 2021 · Apr 30, 2021 $49.5K
Capex Q2 2021 · Apr 30, 2020 $28.27K
Operating Cash Flow Q2 2021 · Apr 30, 2021 −$662.07K
Operating Cash Flow Q2 2021 · Apr 30, 2020 −$206.9K
Cash And Equivalents Q2 2021 · Apr 30, 2021 $6.01K
Cash And Equivalents Q2 2021 · Oct 31, 2020 $201.66K
Stockholders Equity Q2 2021 · Apr 30, 2021 −$7.97M
Stockholders Equity Q2 2021 · Jan 31, 2021 −$7.83M
Stockholders Equity Q2 2021 · Oct 31, 2020 −$7.4M
Stockholders Equity Q2 2021 · Apr 30, 2020 −$6.72M
Stockholders Equity Q2 2021 · Jan 31, 2020 −$6.64M
Stockholders Equity Q2 2021 · Oct 31, 2019 −$6.48M
Current Liabilities Q2 2021 · Apr 30, 2021 $8.35M
Current Liabilities Q2 2021 · Oct 31, 2020 $7.86M
Current Assets Q2 2021 · Apr 30, 2021 $218.17K
Current Assets Q2 2021 · Oct 31, 2020 $330.95K
Total Assets Q2 2021 · Apr 30, 2021 $378.69K
Total Assets Q2 2021 · Oct 31, 2020 $469.23K
Sga Expense Q2 2021 · Apr 30, 2021 $44.18K
Sga Expense Q2 2021 · Apr 30, 2021 $82.82K
Sga Expense Q2 2021 · Apr 30, 2020 $57.78K
Sga Expense Q2 2021 · Apr 30, 2020 $112.06K
Rd Expense Q2 2021 · Apr 30, 2021 $56.65K
Rd Expense Q2 2021 · Apr 30, 2021 $123.45K
Rd Expense Q2 2021 · Apr 30, 2020 $41.31K
Rd Expense Q2 2021 · Apr 30, 2020 $98.09K
Net Income Q2 2021 · Apr 30, 2021 −$189.09K
Net Income Q2 2021 · Apr 30, 2021 −$361.13K
Net Income Q2 2021 · Jan 31, 2021 −$172.04K
Net Income Q2 2021 · Apr 30, 2020 −$209.65K
Net Income Q2 2021 · Apr 30, 2020 −$273.44K
Net Income Q2 2021 · Jan 31, 2020 −$63.79K
Operating Income Q2 2021 · Apr 30, 2021 −$113.15K
Operating Income Q2 2021 · Apr 30, 2021 −$201.79K
Operating Income Q2 2021 · Apr 30, 2020 −$120.33K
Operating Income Q2 2021 · Apr 30, 2020 −$219.98K
Gross Profit Q2 2021 · Apr 30, 2021 $63
Gross Profit Q2 2021 · Apr 30, 2021 $37.15K
Gross Profit Q2 2021 · Apr 30, 2020 −$95
Gross Profit Q2 2021 · Apr 30, 2020 $27.28K
Revenue Q2 2021 · Apr 30, 2021 $95
Revenue Q2 2021 · Apr 30, 2021 $47.33K
Revenue Q2 2021 · Apr 30, 2020 −$211
Revenue Q2 2021 · Apr 30, 2020 $60.29K